HCPLive

Study Assesses Glucose Monitoring Trends in Tweens

Thursday, April 12 (HealthDay News) -- To determine whether adherence and glycemic control change during the transition to adolescence, Joseph R. Rausch, Ph.D., of the Cincinnati Children's Hospital Medical Center, and colleagues conducted a two-year longitudinal study involving 225 children aged 9 to 11 years with type 1 diabetes.

The researchers found that, over the duration of this two-year study, blood glucose monitoring frequency (BGMF) significantly decreased, from 4.9 to 4.5 checks per day, which correlated with a significant increase in HbA1c, from 8.2 to 8.6 percent. The researchers calculated that just one less check of blood glucose per day resulted in an increase in HbA1c of 1.26 percent.

"The magnitude of the effect of declining treatment adherence (BGMF) on glycemic control in young adolescents may be even greater than declines observed among older adolescents. BGMF offers a powerful tool for targeted management of glycemic control for type 1 diabetes during the critical transition to adolescence," the authors write.

Abstract
Full Text (subscription or payment may be required)

During the transition to adolescence, children with type 1 diabetes monitor their blood glucose less frequently, resulting in significant increases in HbA1c levels, according to research published online April 3 in Diabetes Care.

Copyright © 2012 HealthDay. All rights reserved.

Most Popular

Recommended Reading

Resistance training seems to be most effective for people with a low genetic risk for a high body mass index, according to a study published online April 30 in the International Journal of Obesity.

Cigarette smoking continues to decline in about half of American states, according to the latest US government estimates.
Almost one out of every five young women were raped or experienced attempted rape during their freshman year at a large private university in upstate New York, a new study reports.
With the help of a 3-D printer researchers are working on developing a new overtube that can be used during endoscopic submucosal dissection.
$vAR$